Is there an age limit for vaccinating cervical cancer?
The first approved HPV vaccine for preventing cervical cancer was officially launched in the market. Prior to this, the main means of preventing cervical cancer was through cervical screening.
CCTV Finance previously reported that the vaccine is the “Sirius” of British pharmaceutical company GlaxoSmithKline-the bivalent price for two virus strains (HPV-16 and HPV-18) that can cause cervical cancer and the highest risk vaccine.
Regarding the statement that the best age for the vaccine is 9 to 25 years old, Zhang Youzhong, deputy director of the Department of Gynecology and Oncology, Qilu Hospital of Shandong University, said in an interview with Qilu Evening News that even if he is over 25 years old, if he has not been infected with HPV virus, Or it is not infected with the two viruses mentioned above and can still be injected. China’s annual cervical cancer cases account for more than 28% of the world’s, and it is one of the most common malignant tumors for women. Globally, cervical cancer is also the third most common cancer among women aged 15 to 44.
Expert: There are three situations beyond the age of 25. You can also call the
official website of the State Food and Drug Administration to show that HPV Chinese is called human papilloma virus. Most of the currently known more than 100 types of HPV are “low risk” and are not associated with cervical cancer, but 14 of them are classified as “high risk” and two of the highest risk strains (HPV-16 Type and HPV-18 type) can cause about 70% of cervical cancer.
The optimal age for vaccination of the bivalent vaccine “Cirius” this time is 9 to 25 years old. Many over-age netizens have expressed regrets. Can people over 25 years old be vaccinated?
On August 3, Zhang Youzhong, deputy director of the Department of Gynecologic Oncology at Qilu Hospital of Shandong University, said in an interview with Qilu Evening News that 9-25 years old can only be understood as the best age for vaccination. In fact, there are three cases where this vaccine can still be injected: one is that although it is over 25 years old, it has not been infected with HPV virus; the other is that it has been infected with HPV virus, but it is not infected with two types of HPV virus, 16, 18; The third is that although HPV has been infected and precancerous lesions of cervical cancer have occurred, it has recovered and turned cloudy.
According to public information provided by the State Food and Drug Administration, HPV infections are more common among women. Data show that at a certain stage in life, 4 out of 5 women will be infected. If you are infected with high-risk HPV, it may progress to a high degree of cervical lesions or even develop into cervical cancer.
HPV is mainly transmitted through sexual contact, and it can also be infected through direct contact: for example, after touching an item with HPV in your hand, you may bring the virus into the reproductive organs during toileting or bathing; or if the reproductive organ is exposed to HPV Items such as bath towels may be infected.
The quadrivalent vaccine is expected to be listed in the era.
According to CCTV Financial Reports, the general cervical cancer vaccine is divided into two, four, and nine prices. This time it is approved to be marketed in the Mainland. It is GlaxoSmithKline’s HPV bivalent vaccine.
Qiao Youlin, director of the Cancer Epidemiology Laboratory of the Chinese Academy of Medical Sciences, said in an interview with CCTV News that in May this year, the quadrivalent vaccine (based on the bivalent vaccine, two HPV viruses were targeted, and the applicable age is 20 to 45 years old) It has been approved by the state and is expected to be listed at the end of the year.
As for when the public can use the nine-valent vaccine, Qiao Youlin said that the nine-valent vaccine has not yet entered clinical trials, and the expected time is “very long.”
Will HPV vaccine be included in medical insurance in the near future? Zhao Fanghui, deputy director, professor and doctoral tutor of the Department of Cancer Epidemiology, Cancer Hospital, Chinese Academy of Medical Sciences, believes that it is unlikely that the price of the vaccine will be reduced through market competition, and then it will be covered by medical insurance.
Regarding cervical cancer vaccines, the State Food and Drug Administration reminded that since there are more than 10 high-risk subtypes of HPV virus associated with cervical cancer, and the vaccines are only targeted at some of them, even if they are vaccinated, they should still be regularly Screening.